BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn Trial at the 2024 Maxim Healthcare Virtual Summit (PRNewswire) - Oct 7, 2024 - "BrainStorm Cell Therapeutics Inc...today announced its participation in the 2024 Maxim Healthcare Virtual Summit...During the session, Mr. Lebovits will provide an update on the planned Phase 3b clinical trial for NurOwn, the company's investigational cell therapy for ALS. This event presents a valuable opportunity to engage with the investment community and share in-depth insights into the upcoming trial."
Clinical • Amyotrophic Lateral Sclerosis • CNS Disorders
|